Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

about

Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension.

P2860

Q48033355-509C29D3-BDE7-4D8E-B856-A2A634B990EC

P2860

Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

Item

http://www.wikidata.org/entity/Q40814361

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Survival protection by bodywei ...... pulmonary artery hypertension.

@en

type

Item

label

Survival protection by bodywei ...... pulmonary artery hypertension.

@en

prefLabel

Survival protection by bodywei ...... pulmonary artery hypertension.

@en

P1476

Survival protection by bodywei ...... pulmonary artery hypertension.

@en

P2093

Bruno Formichi

http://www.w3.org/2001/XMLSchema#string

Carlo Giuntini

http://www.w3.org/2001/XMLSchema#string

Carlo Marini

http://www.w3.org/2001/XMLSchema#string

Carolina Bauleo

http://www.w3.org/2001/XMLSchema#string

Claudio Michelassi

http://www.w3.org/2001/XMLSchema#string

Edoardo Airò

http://www.w3.org/2001/XMLSchema#string

Giuseppe Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and the risk of heart failure

Clinical classification of pulmonary hypertension.

Systemic sclerosis-associated pulmonary arterial hypertension

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Excess deaths associated with underweight, overweight, and obesity.

Pulmonary arterial hypertension associated with systemic sclerosis.

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.

P2888

s11739-016-1446-2

P304

941-952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-016-1446-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299986339

http://www.w3.org/2001/XMLSchema#string

P698

27052360

http://www.w3.org/2001/XMLSchema#string

Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

about

P2860

P2860

Survival protection by bodyweight in isolated scleroderma-related pulmonary artery hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698